Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 232-094-6 | CAS number: 7786-30-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Skin sensitisation study has been conducted with magnesium chloride hexahydrate. The result can be extrapolated to magnesium chloride anhydrous.
There was no evidence of sensitisation in the MgCl2 group at the challenge and the percentage of animals sensitised was 0 %.
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- January 2010 till March 2010
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Version / remarks:
- 17 July 1992
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2600 (Skin Sensitisation)
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- A LLNA test was ordered in first intention and preliminary experiments for the LLNA was carried out. However, these preliminary experimenst for the LLNA with Magnesium Chloride revealed that there is no suitable vehicle for this test. Therefore, the LLNA was cancelled and it was decided to perform the Guinea Pig Maximization test instead.
The test has been ordered in September 2009 and the protocol of the guinea pig maximisation test was completed on 12 March 2010. The LLNA 429 was not formally adopted by the OECD until 22 July 2010. Also, according to the OECD guideline 429, there are limitation to LLNA 429 including false negatives for certain metals. - Specific details on test material used for the study:
- - Name of test material (as cited in study report): Magnesium chloride hexahydrate
- Physical state: Colourless; Solid, crystals
- Stability after opening: Instable after repeated contact to air
- Storage condition of test material: At room temperature, in a tightly closed package.
- pH: 5.5 - 7.0 (5% solution at 20 °C)
- Solvent: Water
No further information on the test material was stated. - Species:
- guinea pig
- Strain:
- Hartley
- Sex:
- female
- Details on test animals and environmental conditions:
- Species/strain: Healthy Crl: HA - Guinea pigs (Full-Barrier). Source: Charles River, 97633 Sulzfeld, Germany
Sex: female (non-pregnant, nulliparous)
Age at the beginning of the study: approximately 5 weeks old
Body weight at the beginning of the study: 354 - 408 g
The animals were derived from a controlled full-barrier maintained breeding system (SPF).
A health inspection was performed to ensure the good state of health of the animals.
Housing and Feeding Conditions: semi barrier in an air-conditioned room, temperature: 22 (+/- 3)°C, relative humidity: 55 (+/- 10)%, artificial light, sequence being 12 hours light, 12 hours dark, air change: at least 10 x / hour, free access to to autoclaved hay and to Altromin 3122 maintenance diet, rich in crude fibre, free access to tap water, the animals were kept in groups in Terluran - cages on Altromin saw fibre bedding, adequate acclimatisation period (at least five days). - Route:
- intradermal
- Vehicle:
- physiological saline
- Remarks:
- physiological saline 0.9% NaCl and vaseline
- Concentration / amount:
- A concentration of 5% for the intradermal induction (0.5 g of the test item was suspended ad 10 mL of vehicle to gain a 5% solution (w/w)).
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: vaseline
- Concentration / amount:
- A concentration of 50% for the dermal induction (3 g of the test item was suspended in vehicle ad 6 g to gain a 50% suspension (w/w)).
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: vaseline
- Concentration / amount:
- A concentration of 50% for the challenge application (5 g of the test item was suspended in 5 g of vehicle to gain a 50% suspension (w/w)).
- No. of animals per dose:
- 10
- Details on study design:
- Induction: First Stage, Intradermal Injection. Three pairs of intradermal injections of 0.1 mL volume were given in the shoulder region which was cleared of hair by clipping so that one of each pair lies on each side of the midline.
Test group Day 0:
Injection 1: a 1:1 mixture (v/v) FCA/physiological saline 0.9% NaCl
Injection 2: a 5% concentration of the test item in physiological saline 0.9% NaCl
Injection 3: a 5% concentration of the test item formulated in a 1:1 mixture (v/v) FCA/physiological saline 0.9% NaCl
Control group Day0:
Injection 1: a 1:1 mixture (v/v) FCA/physiological saline 0.9% NaCl
Injection 2: 100% physiological saline 0.9% NaCl
Injection 3: 50% physiological saline 0.9% NaCl in a 1:1 mixture (v/v) FCA/physiological saline 0.9% NaCl
Injections 1 and 2 were given close to each other and nearest to the head, while injection 3 is given toward the caudal part of the test area.
Induction: Second Stage, Topical Application
Test and control group: Day 6: approximately twenty-four hours before the topical application the test area was painted with 0.5 mL of 10% sodium lauryl sulphate in vaseline after close clipping, in order to create a local irritation.
Test group Day 7: the test item was suspended in vaseline at a concentration of 50%. A patch was fully loaded with 0.5 g of the prepared test item, applied to the test area and held in contact by an occlusive dressing for 48 hours.
Challenge: Topical Application
The flanks of treated animals were cleared of hair by close-clipping.
Test and control group: Day 20: the test item was suspended in vaseline at a concentration of 50%. A patch, loaded with 0.5 g of the prepared test item was applied to the left flank of the animals. The patches were held in contact by an occlusive dressing for 24 hours. The application area was not rinsed with water.
Observation Period
Approximately 21 hours after removing the patch, the challenge area was cleared of hair by the use of a depilatory cream. Approximately 24 and 48 hours after removing the patch the skin reaction was observed and recorded according to the grades shown below. Additionally all animals were observed for signs of toxicity at least once daily during the test period. - Challenge controls:
- Number of animals in the negative control group: 5
Induction: First Stage, Intradermal Injection
Day 0
Injection 1: a 1:1 mixture (v/v) FCA/physiological saline 0.9% NaCl
Injection 2: 100% physiological saline 0.9% NaCl
Injection 3: a 50% (v/v) formulation of NaCl 0.9% in a 1:1 (v/v) mixture FCA/physiological saline 0.9% NaCl
Injections 1 and 2 were given close to each other and nearest to the head, while injection 3 is given toward the caudal part of the test area.
Induction: Second Stage, Topical Application
Day 6: approximately twenty-four hours before the topical application the test area was painted with 0.5 mL of 10% sodium lauryl sulphate in vaseline after close clipping, in order to create a local irritation.
Day 7 : a patch was fully loaded with 0.5 g of the vaseline and applied to the test area and held in contact by an occlusive dressing for 48 hours.
Challenge: Topical Application
The flanks ofcontrol animals were cleared of hair by close-clipping.
Day 20: a patch loaded with 0.5 mL of the vehicle was applied to the right flank. The patches were held in contact by an occlusive dressing for 24 hours. The application area was not rinsed with water. - Positive control substance(s):
- yes
- Remarks:
- Positive-control substance: mercaptobenzothiazole, purity 98%. Concentrations: 2% induction I phase in cottonseed oil, 25% induction II phase in vaseline, 15% challenge in vaseline.
- Positive control results:
- The sensitisation rate after application of the positive-control substance mercaptobenzothiazole (15% in vaseline) was 100%, confirming the reliability of the test system.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 50%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- No effect
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 50%. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: No effect.
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 50%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- No effect
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 50%. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: No effect.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 50%
- No. with + reactions:
- 1
- Total no. in group:
- 5
- Clinical observations:
- Erythema grade 1 was observed after 24 hours in one animal.
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 50%. No with. + reactions: 1.0. Total no. in groups: 5.0. Clinical observations: Erythema grade 1 was observed after 24 hours in one animal..
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 50%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Clinical observations:
- No effect
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 50%. No with. + reactions: 0.0. Total no. in groups: 5.0. Clinical observations: No effect.
- Reading:
- 1st reading
- Group:
- positive control
- Dose level:
- 15%
- No. with + reactions:
- 10
- Total no. in group:
- 10
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Under the conditions of this study, there was no evidence of sensitisation in the test item group at the challenge and the percentage of animals sensitised was 0%.
- Executive summary:
The test for sensitisation was performed on the guinea pig according OECD Guidelines No. 406.
The following concentrations were determined by a preliminary test:
- intradermal induction: 5% of the test item, vehicle: physiological saline 0.9% NaCl
- Dermal induction: 50% of the test item, vehicle: vaseline
- Challenge exposure (the highest non-irritating dose): 50% of the test item, vehicle: vaseline.
During the induction slight signs of irritation were observed. These findings confirmed the validity of the study.
After the challenge exposure: no erythema was observed in any of the test animals at any time. Erythema grade 1 was observed after 24 hours in one animal of the control group. No oedema was observed in any animal at any time.
There was no evidence of sensitisation at the challenge and the percentage of animals sensitised was 0%.
Reference
The animals of the test group showed no reduced weight gain compared to historical data.
All animals of both groups survived throughout the test period.
There are signs of irritation during the induction
Intradermal Induction I (24 hours reading):
- Injection site 1: erythema grade 2 in 5/5 control and 10/10 test animals, oedema grade 2 in 4/5 control and 10/10 test animals, oedema grade 1 in 1/5 control animals
- Injection site 2: erythema grade 1 in 9/10 test animal, eschar in 8/10 test animals
- Injection site 3: erythema grade 2 in 1/5 control and 1/10 test animals, erythema grade 1 in 1/5 control and 9/10 test animals, oedema grade 2 in 1/5 control and 1/10 test animals, oedema grade 1 in 1/5 control and 2/10 test animals eschar in 1/5 control and 6/10 test animals
Intradermal Induction I (48 hours reading):
- Injection site 1: erythema grade 2 in 1/5 control and 3/10 test animals, erythema grade 1 in 4/5 control and 7/10 test animals, oedema grade 2 in 1/5 control and 3/10 test animals, oedema grade 1 in 4/5 control and 7/10 test animals, necrosis (Ø 0.4 cm) in 1/10 test animals eschar in 1/5 control and 1/10 test animals
- Injection site 2: erythema grade 1 in 4/5 test animals
- Injection site 3: erythema grade 1 in 2/5 control and 9/10 test animals, oedema grade 1 in 1/5 control and 1/10 test animals
Dermal Induction II (48 hours exposure, occlusive):
- Immediately after removing the patch: Desquamation in 1/5 control animals, erythema grade 1 in 2/10 test animals
24 hours after removing the patch: Eschar in 5/5 control and 10/10 test animals, erythema grade 1 in 1/10 test animals, desquamation in 1/10 test animals
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
There is only one study available for MgCl2: Ahuja V., 2010 (reliability 1). This key study was performed on the guinea pig (OECD 406). The following concentrations were determined by a preliminary test:
- Intradermal induction: 5% of the test item, vehicle: physiological saline 0.9% NaCl
- Dermal induction: 50% of the test item, vehicle: vaseline
- Challenge exposure (the highest non-irritating dose): 50% of the test item, vehicle: vaseline.
After the challenge exposure, no erythema was observed in any of the test animals at any time and no oedema was observed in any animal at any time. There was no evidence of sensitisation at the challenge and the percentage of animals sensitised was 0%.
Justification for classification or non-classification
On the basis of study result, the MgCl2 was not classified for skin sensitisation under the CLP regulation 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.